Table 3.
Spearman correlations between inflammatory mediators, average residual limb pain intensity, and pain catastrophizing in the full sample (n=76).
Systemic Mediator | Average Pain | P value | PCS | P value |
---|---|---|---|---|
IFN-γ | 0.11 | 0.339 | 0.18 | 0.119 |
IL-10 | 0.15 | 0.191 | 0.03 | 0.804 |
IL-13 | −0.45 | 0.000 | −0.29 | 0.010 |
IL-1β | 0.06 | 0.604 | 0.13 | 0.280 |
IL-2 | −0.24 | 0.038 | −0.15 | 0.184 |
IL-4 | −0.22 | 0.054 | −0.06 | 0.612 |
IL-6 | 0.17 | 0.137 | 0.10 | 0.374 |
IL-8 | 0.26 | 0.024 | 0.25 | 0.030 |
TNF-α | 0.30 | 0.008 | 0.18 | 0.129 |
IL-12 | 0.31 | 0.006 | 0.24 | 0.037 |
IL-17 | 0.21 | 0.065 | 0.10 | 0.369 |
IL-5 | 0.04 | 0.706 | 0.08 | 0.517 |
IL-7 | −0.03 | 0.774 | 0.12 | 0.293 |
TNF-β | 0.43 | 0.000 | 0.39 | 0.001 |
VEGF | 0.19 | 0.104 | 0.17 | 0.139 |
IL-15 | −0.01 | 0.906 | 0.02 | 0.855 |
IL-16 | 0.09 | 0.439 | 0.21 | 0.077 |
IL-1a | 0.11 | 0.334 | 0.03 | 0.773 |
Eotaxin | 0.02 | 0.856 | −0.04 | 0.775 |
Eotaxin-3 | −0.27 | 0.017 | −0.10 | 0.385 |
IP-10 | 0.07 | 0.557 | 0.02 | 0.887 |
MCP-1 | −0.03 | 0.813 | 0.01 | 0.917 |
MCP-4 | −0.08 | 0.496 | −0.06 | 0.628 |
MDC | 0.04 | 0.728 | −0.04 | 0.763 |
MIP-1α | 0.06 | 0.632 | −0.03 | 0.831 |
MIP-1β | 0.14 | 0.238 | 0.11 | 0.358 |
TARC | −0.11 | 0.366 | 0.01 | 0.947 |
Flt-1 | 0.13 | 0.262 | 0.15 | 0.194 |
PIGF | 0.31 | 0.008 | 0.34 | 0.003 |
Tie2 | 0.35 | 0.002 | 0.22 | 0.059 |
VEGF-C | −0.15 | 0.185 | −0.04 | 0.756 |
VEGF-D | −0.05 | 0.664 | 0.20 | 0.087 |
bFGF | −0.13 | 0.270 | 0.06 | 0.595 |
CRP | 0.20 | 0.092 | 0.05 | 0.671 |
SAA | 0.33 | 0.004 | 0.21 | 0.072 |
ICAM-1 | 0.43 | 0.000 | 0.44 | 0.000 |
VCAM-1 | 0.11 | 0.346 | 0.21 | 0.074 |
Set-wise p value | --- | 0.008 | --- | 0.005 |